While lower price cards can help reduce the load of significant drug charges inside the short-term, they do not tackle the systemic problems driving up prescription prices while in the U.S. Broader plan adjustments could tackle the basis causes of rising drug rates, for instance insufficient transparency in pricing plus the position of intermediari